Objectives: Pancreatic cancer has a very poor prognosis, largely due to its propensity for early local and distant spread. Histopathologically, most pancreatic cancers are characterized by a prominent stromal/fibrous reaction in and around tumor tissue. The aims of this study were to determine whether (1) the cells responsible for the formation of the stromal reaction in human pancreatic cancers are activated pancreatic stellate cells (PSCs) and (2) an interaction exists between pancreatic cancer cells and PSCs that may facilitate local and distant invasion of tumor.
P
ancreatic cancer has a very poor prognosis, largely due to its propensity for early local invasion and distant metastasis. 1 Although aggressive combination therapy such as surgery with chemotherapy and irradiation has been reported to improve the 5-year survival rate from 3% to 20%-30%, 2 this is only true for early resectable cancers and the overall outcome remains poor.
Alternative approaches to therapy for pancreatic cancers are now being sought through research into the pathobiology of these tumors. Recent genetic studies have provided clear evidence of increased activation of oncogenes such as the Kras gene and decreased activities or loss of tumor suppressor genes (including DPC4, p16, p53, SMAD4) in pancreatic cancers. [3] [4] [5] [6] As a result of these findings, methods such as modulation of oncogene and tumor suppressor gene expression are under study for the treatment of pancreatic cancer. 5 However, the large number of critical genes that are altered in this disease suggests that gene therapy strategies would have to be very complex and may be quite difficult to achieve clinically.
One aspect of the pathology of pancreatic cancer that has received little attention to date is the pronounced desmoplastic (stromal) reaction around tumor tissue. This reaction is a characteristic feature of a majority of pancreatic tumors. 7 It is com-posed of connective tissue (predominantly collagen type I and other glycoproteins) and "new" blood vessels and is associated with proliferation of fibroblastic cells, which sometimes can outnumber local tumor cells. The relationship between the stromal reaction and local invasion or subsequent distant metastasis of pancreatic cancer is unknown. Loss of basement membrane integrity around the tumor is frequently observed in spreading pancreatic cancers, indicating that proteolytic degradation of type IV collagen and other extracellular matrix proteins may be important in the process of invasion and spread of the cancer. 8, 9 In addition, the formation of new blood vessels in the stromal tissue may help promote local as well as distant spread of pancreatic cancers. 10, 11 It is of interest to note that the less aggressive mucinous type of pancreatic carcinoma is associated with very little stromal reaction around the tumor. 12 Thus, an understanding of the biology of the cells involved in the formation and degradation of stromal tissue around pancreatic tumors and of the interaction between stromal cells and tumor cells may yield valuable insights into the pathogenesis of pancreatic tumor growth and invasion.
For this study, we hypothesized that the cells responsible for the production of the desmoplastic reaction around pancreatic tumors are pancreatic stellate cells (PSCs). Recent studies have established that these cells are the principal source of collagen in fibrosis associated with chronic pancreatitis. [13] [14] [15] [16] PSCs can be identified by positive staining for stellate cell selective markers such as the cytoskeletal proteins desmin and glial fibrillary acidic protein. 13, 14 When activated during pancreatic injury by factors such as oxidant stress or cytokines, PSCs assume a myofibroblast-like phenotype and exhibit increased expression of the cytoskeletal protein ␣-smooth muscle actin (␣SMA) in the cytoplasm. [17] [18] [19] [20] It is possible that an interaction exists between PSCs and tumor cells that promotes local and distant metastasis of tumors. Therefore, the aims of the study were to (1) characterize stromal cells in the desmoplastic reaction of pancreatic cancer using human pancreatic cancer sections and (2) determine whether an interaction exists between pancreatic cancer cells and PSCs by examining the influence of conditioned medium from 2 pancreatic cancer cell lines on the proliferation and activation of cultured PSCs.
MATERIALS AND METHODS

Human Pancreatic Cancer Sections
Archival formaldehyde-fixed and paraffin-embedded pancreatic tissue was obtained from the Departments of Anatomic Pathology at 3 teaching hospitals in Sydney and also from the Department of Surgery, University of Heidelberg (12 specimens). Pancreatic tissue was also obtained prospectively from patients with documented pancreatic cancer (5 specimens). Freshly resected samples were divided into portions for formalin fixation (for paraffin sections), for embedding in OCT and freezing in ␣-methylbutane at −80°C (for frozen sections).
Histologic analysis of human pancreatic cancer samples was aimed at examining the stromal areas in each specimen for (1) the presence of collagen, (2) the presence of PSCs and their state of activation, (3) the correlation between the extent of the stromal reaction and PSC activation, and (4) the cellular source of collagen in the stromal reaction. This was achieved by staining serial sections of each specimen for collagen, desmin and GFAP (stellate cell selective markers), ␣SMA (a marker of activated stellate cells) and mRNA for collagen using methods detailed below.
Collagen staining was performed using the Sirius Red method. Desmin, GFAP, and ␣SMA staining was performed using immunohistochemical methods. Frozen sections were prepared for analysis of desmin and GFAP expression by acetone fixation at 4°C for 10 minutes followed by air-drying. Sections were then washed with TBS 3 times. Paraffin-fixed pancreatic sections were prepared for ␣SMA staining by rehydration. All sections were incubated with 1% H 2 O 2 in methanol for 30 minutes to block endogenous peroxidase activity. After washing, sections were incubated with a blocking solution containing TBS, 1% bovine serum albumin (BSA), and 10% goat serum to prevent nonspecific binding of antibody. Sections were then incubated with the primary antibody of interest in blocking solution [mouse monoclonal anti-desmin antibody (1:100) or rabbit polyclonal anti-GFAP (1:500) or mouse monoclonal anti-␣SMA antibody (1:100); DAKO, Botany, Australia] overnight at 4°C. After further washes, the relevant secondary antibody (horseradish peroxidaseconjugated goat anti-mouse or anti-rabbit IgG, 1:100) was applied for 30 minutes at room temperature. Sections were then washed, and color was developed using the 3,3-diaminobenzidine tetrahydrochloride (DAB) substrate chromogen system (DAKO, Botany). Sections were counterstained with Mayer hematoxylin for 5 minutes. Negative controls comprised sections incubated with isotype IgG or blocking solution without primary antibody.
Correlation between the extent of the stromal reaction and PSC activation in pancreatic cancer sections was assessed by morphometric analysis of serial sections of human pancreatic cancer tissue stained for collagen (using Sirius Red) and ␣SMA (by immunostaining). Stained sections were analyzed by systematic random sampling. In each field of each section, the area density of stromal tissue, as assessed by collagen staining, and the area density of PSC activation, as assessed by ␣SMA staining, was determined by overlaying a pointcounting grid on a projected digital image. Images were captured with a Spot Cooled Color Digital camera (Diagnostic Instruments). To ensure an unbiased result, sections were counted in random order by an investigator blinded to the pairing of ␣SMA and collagen staining.
The cellular source of collagen in stromal areas was assessed by dual staining of human pancreatic cancer sections for ␣SMA (by immunostaining) and for procollagen ␣ 1 (I) mRNA (by in situ hybridization). Colocalization of positive immunostaining for ␣SMA with staining for collagen mRNA in the same cells would suggest that activated PSCs are the source of collagen in the stromal reaction surrounding the tumors.
In Situ Hybridization for Procollagen ␣ 1 (I) mRNA
In situ hybridization for procollagen ␣ 1 (I) mRNA was performed using previously described methods. 15, 21, 22 Briefly, a 1500-bp fragment of human procollagen ␣ 1 (I) cDNA was subcloned into pGEM 11Z vector and then subjected to alkaline hydrolysis to produce a 300-bp fragment for use in in situ hybridization. Digoxigenin-labeled riboprobes for sense (control) and antisense were obtained by in vitro transcription with SP6 and T7 polymerases. In situ hybridization was performed with 5-µm thick sections. After hybridization, sections were washed to remove unbound probe and incubated with alkaline phosphatase conjugated antidigoxigenin polyclonal sera (1:200) at room temperature for 2 hours. Unbound antibody was removed by washing prior to color visualization with nitroblue tetrazolium chloride/5-bromo-4-chloro-3-indoyl phosphate in the dark room at room temperature for 16 hours. Unbound complex was removed by washing, and sections were then subjected to immunohistochemistry for ␣S⌴〈.
Interaction of Cultured PSCs and Pancreatic Cancer Cells
Cultured rat PSCs were incubated with conditioned media from 2 human pancreatic cancer cell lines PANC-1 (a moderately differentiated cell line) and MiaPaCa-2 (a poorly differentiated cell line). PSC proliferation and ␣SMA expression were then assessed as indicators of cell activation.
Collection of Conditioned Medium
Human pancreatic cancer cell lines (PANC-1 and MiaPaCa-2) were cultured according to supplier's instructions (American Type Culture Collection, Rockville, MD). PANC-1 cells and MiaPaCa-2 cells were seeded at a density of 2 × 10 6 cells and 3 × 10 6 cells per 75-cm 2 flask, respectively. Twentyfour hours later, cells were rinsed with 3 mL Dulbecco modified Eagles medium (DMEM) (Thermo Electron Corporation, Victoria, Australia) and cultured for a further 24 hours in DMEM containing 0.2% fetal bovine serum (FBS) (Invitrogen Pty Ltd., Melbourne, Australia). This medium was then collected and centrifuged at 1500 rpm for 10 minutes at 4°C, and the supernatant (conditioned medium) was removed and stored for later use. Before use in PSC activation experiments, dialyzed/lyophilized cancer cell secretions were resuspended in the culture medium used for PSCs [Iscove Modified Dulbecco medium (IMDM)] (Invitrogen Pty Ltd.), so that the conditioned media were either undiluted or diluted 1:2 and 1:4 of the original collection.
Isolation and Culture of PSCs
Rat PSCs were isolated by density gradient centrifugation as detailed previously. 13 This technique yields a preparation of PSCs that is devoid of contamination by endothelial cells or macrophages, as evidenced by negative staining for the markers factor VIII and ED1, respectively. 13 Freshly isolated stellate cells were cultured in 25 cm 2 plastic culture flasks containing IMDM supplemented with 10% FBS at 37°C in humidified 95% air/5% CO 2 atmosphere. At confluence, cells were harvested, counted and replated at equal seeding densities for use in the experiments described below. All experiments were performed with culture-activated cells (passages 1-3).
Effect of Tumor Cell Secretions on PSCs
Cultured PSCs were incubated at 37°C for 24 hours with conditioned medium from established tumor cell cultures collected as described earlier. Stellate cells incubated with culture medium alone were used as controls. Stellate cells were then assessed for:
Cell Proliferation
This was assessed using the CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega, WI) per the manufacturer's instructions. Briefly, PSCs were seeded (3500 cells/well) in triplicate in the wells of a 96-well plate. Upon reaching 70% confluence, PSCs were treated for 24 hours with either control (lyophilized/desalted DMEM resuspended in 0.2% FBS/IMDM) or cancer cell secretions (as outlined above). MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] reagent (20 µL MTS reagent/100 µL sample) was then added to each well, and the plates incubated for a further 4 hours at 37°C in a humidified, 5% CO 2 atmosphere. Absorbance was recorded at 490 nm using a 96-well plate reader.
␣SMA Expression
Levels of ␣SMA in cells incubated with conditioned media from PANC-1 and MiaPaCa-2 cells were determined by Western blotting of cell lysate proteins as described previously, 18 ,20 using a monoclonal mouse antibody to ␣SMA (Sigma Chemical Co., St. Louis, MO). Briefly, at the end of the incubation period, cells were harvested by trypsinization, and cell lysates obtained by incubating the cells overnight in lysis buffer (50 mmol/L Tris-HCl pH 7.5, 150 mmol/L NaCl, 1% Triton X-100, 0.5% deoxycholate, 1% sodium dodecyl sulfate (SDS), 1 mmol/L sodium orthovanadate, 2 mmol/L ethylenediaminetetraacetic acid, 10 mmol/L NaF, 10 mg/mL aprotinin, 10 mg/mL leupeptin, 1 mmol/L phenylmethylsulfonyl fluoride). Samples were then centrifuged at 2200g for 10 minutes and the supernatant was harvested.
Protein levels in cell lysate supernatants were measured using a BCA protein estimation kit (Pierce, Rockford, IL) per
Desmoplastic Reaction in Pancreatic Cancer the manufacturer's instructions, using BSA as the standard. Proteins (5 µg) from each sample were separated by gel electrophoresis using a 15% SDS polyacrylamide gel. Known molecular weight protein standards were run alongside the samples. Separated proteins were transferred onto nitrocellulose membrane using a commercial semidry blotting apparatus (Biorad, Richmond, CA). The nitrocellulose membrane was then incubated at room temperature with 5% skim milk powder in Tris-buffered saline (pH 7.6) for 1 hour to prevent nonspecific binding of antibody. This was followed by incubation with the primary antibody (monoclonal mouse anti-␣SMA antibody, 1:200) in fresh blocking solution at room temperature for 1 hour. The filter was then washed and incubated with the secondary antibody (goat anti-mouse IgG, 1:1000; Amersham International, Buckinghamshire, UK) for 1 hour at room temperature. ␣SMA bands were detected by the enhanced chemiluminescence technique using the Amersham ECL kit and quantified by densitometry of scanned autoradiographs (Biorad Gel Documentation System, Biorad Sydney, Australia). Densitometry readings were expressed as integrated optical densities (arbitrary densitometer units calculated from the density as well as the size of each band) per mg protein loaded on the membranes.
RESULTS
Human Pancreatic Cancer Sections
Staining of PSCs
Staining of serial frozen sections of pancreatic cancer tissue from 5 patients demonstrated that stromal areas of the sections exhibited positive staining for desmin and GFAP (stellate cell selective markers) as well as for ␣SMA (a marker of the activated phenotype of PSCs). In contrast, tumoral areas of the sections did not exhibit any staining for desmin, GFAP or ␣SMA (Fig. 1) . The prominent staining for desmin, GFAP, and ␣SMA in stromal areas also contrasts with the previously reported minimal staining for these proteins in normal pancreas. 15, 16 These findings indicate that the stromal cells in the desmoplastic reaction in pancreatic cancers are PSCs in their activated state.
Colocalization of Staining for Collagen and ␣SMA in Pancreatic Cancer
As expected, all pancreatic cancer sections examined exhibited prominent Sirius Red staining for collagen in stromal areas of the section. No collagen staining was found in tumoral areas (Fig. 2) . Serial pancreatic sections from 8 pancreatic cancer patients demonstrated colocalization of staining for collagen and ␣SMA in stromal areas (Fig. 3) . Five of these 8 sections contained both tumoral tissue and normal pancreas, and it was of interest to note that the areas of normal pancreas at a distance from the tumor elements exhibited minimal fibrosis and insignificant ␣SMA staining (data not shown). These findings indicate that PSCs situated at a distance from tumor cells are not activated while those in the vicinity of tumor cells undergo significant activation.
Morphometric analysis of the extent of stromal deposition and extent of PSC activation demonstrated a close correlation between the 2 parameters (correlation coefficient = 0.77) (Fig. 4) , indicating that the amount of collagen deposited may be dependent on the number of activated PSCs in the desmoplastic reaction. Importantly, dual-staining studies (␣SMA plus in situ hybridization for procollagen mRNA) indicated that activated PSCs were the predominant source of collagen in the stromal reaction in pancreatic cancers. As depicted in Figure 5 , it was observed that the expression of procollagen mRNA was limited to the cells exhibiting positive staining for ␣SMA in the stromal reaction. No such staining was observed in the tumoral elements. It was also noted that a minority of stromal cells appeared to stain positively for only 1 of the 2 markers. There are 2 possible explanations for the latter observation: 1. Stellate cell activation and fibrogenesis is a dynamic process. It is well established that the expression of ␣SMA is one of the earliest events in stellate cell activation, occurring before the deposition of collagen. 23 Thus, at any point in time during fibrogenesis, there will be some stellate cells that are in the early phase of activation (expressing only ␣SMA), while others will be in the late phase of activation expressing marked levels of both ␣SMA and collagen mRNA. 21, 24, 25 It is possible that a similar dynamic process occurs during the production of the stromal reaction in pancreatic cancer, accounting for the lack of collagen mRNA staining in some cells. 2. The star-shaped morphology PSCs (typified by a central cell body containing the nucleus and numerous cytoplasmic processes extending outward from the cell body) means that in any one plane of sectioning, there will be some cells that are only represented by their cytoplasmic processes (where ␣SMA staining is maximal) and others that show only the cell body and nucleus (where staining for collagen mRNA is maximal). This would explain why some cells appear to be positive for collagen mRNA and not ␣SMA and vice versa.
Interaction Between PSCs and Pancreatic Cancer Cells
The effects of conditioned media from PANC-1 and MiaPaCa-2 human pancreatic cancer cell lines on PSC activation are as follows.
Cell Proliferation
Incubation with undiluted conditioned media from PANC-1 and MiaPaCa-2 cancer cell lines significantly increased PSC proliferation (Fig. 6) . The increase in cell proliferation persisted in PSCs incubated with diluted conditioned medium (1:2 and 1:4) from MiaPaCa-2 but not in PSCs incubated with diluted conditioned medium from PANC-1 cells.
␣SMA Expression
Exposure of PSCs to undiluted conditioned medium from PANC-1 and MiaPaCa-2 cells did not change ␣SMA expression in PSCs (densitometry data, percentage of control mean ± SEM: PANC-1, 142.7 ± 34.1; MiaPaCa-2, 127.8 ± 27.2). In contrast, incubation with diluted (1:2) conditioned medium from PANC-1 cells (but not MiaPaCa-2) resulted in a significant increase in ␣SMA expression (Fig. 7) .
DISCUSSION
This study demonstrated the presence of PSCs (as assessed by staining for the stellate cell selective markers desmin and GFAP) in their activated phenotype (as indicated by ␣SMA expression) in the desmoplastic reaction in human pancreatic cancers. It was also shown for the first time that (1) activated PSCs are the predominant source of collagen in the desmoplastic reaction in pancreatic cancers and (2) pancreatic cancer cell secretions activate PSCs in vitro (as indicated by increased proliferation and increased ␣SMA expression), suggesting that tumor cells have the ability to influence stromal cell function. All human pancreatic cancer sections examined exhibited abundant stromal tissue in keeping with previous reports of a prominent desmoplastic reaction observed in a majority of pancreatic cancers. Sirius Red staining demonstrated that one of the major components of this stromal tissue was collagen. Staining of serial sections of human pancreatic cancer tissue showed that staining for collagen was colocalized with positive staining for ␣SMA expression, indicating the presence of activated PSCs in the stromal areas. Our findings concur with those recently reported by Yen et al 26 using resected pancreatic cancer tissue. Morphometric analysis revealed a close correlation between the extent of collagen expression and that of ␣SMA expression in fibrotic areas. This observation suggests that the amount of collagen deposited in the stromal reaction may be dependent on the number of activated PSCs in the area. This concept is further supported by our dual-staining studies for ␣SMA and procollagen mRNA expression, which demonstrated that procollagen mRNA was expressed only in activated PSCs (␣SMA-positive cells) in stromal areas. This observation indicates that activated PSCs are the predominant source of collagen in the stromal reaction.
It is generally accepted that neoplastic and no-neoplastic elements in tissues can exert a variety of interactive effects on each other that alter angiogenesis, extracellular matrix components, epithelial-mesenchymal interactions, substratum adhesiveness, and cancer-directed immune responses, all of which influence tumor behavior. 27 Thus, it is possible that factors produced by pancreatic tumor cells influence the activation of PSCs in the stroma surrounding the tumor, thereby affecting the growth and progression of the disease. Our observation that areas of relatively normal pancreas at a distance from the tumor elements exhibit minimal fibrosis and insignificant ␣SMA staining provide support for the concept that tumor cell secretions in vivo activate PSCs in a paracrine manner. This study provided novel findings with respect to the influence of pancreatic tumor cell secretions on the biology of PSCs. We demonstrated that conditioned media from both PANC-1 (a moderately differentiated cell line) and MiaPaCa-2 (a poorly differentiated cell line) significantly increase PSC proliferation. In addition, diluted conditioned medium from PANC-1 cells (but not from MiaPaCa-2 cells) significantly increases ␣SMA expression in PSCs. The reasons for the observed difference in the effect of PANC-1 and MiaPaCa-2 secretions on ␣SMA expression in PSCs are unclear but may reflect differences in the complement of putative activating factors (growth factors/cytokines) secreted by the 2 cell lines.
It was also noted with interest that ␣SMA expression in PSCs was unchanged upon exposure to concentrated PANC-1 secretions but was significantly increased in the presence of diluted PANC-1 secretions. The reason for this apparent discrepancy is not immediately apparent, but 2 possibilities may be considered: (1) dilution of conditioned medium leads to the dilution of inhibitory factor(s)/cytokines in the medium, thereby allowing PSC activation and (2) stellate cells respond differently to different doses of the same cytokine. In this regard, it was demonstrated that hepatic stellate cell activation (as assessed by collagen synthesis) is stimulated by interleukin-6 (IL-6) at a concentration of 20 ng/mL but is inhibited at the higher concentration of 40 ng/mL. 28 Similar results have been reported with PSCs exposed to a range of concentrations of the cytokines IL-6 or TNF, where PSC activation was evident only at the lower concentrations of each cytokine. 20 Candidate factors in cancer cell secretions that may be responsible for the observed activation of PSCs remain to be identified but, as noted earlier, may include growth factors such as transforming growth factor ␤ (TGF␤), platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF). Expression of TGF␤ and of its receptor are known to be increased in pancreatic cancer-associated stromal cells. 29 It has also been shown that pancreatic cancer cells lose their ability to respond to the growth-suppressive effects of TGF␤ due to defective intracellular signaling and/or decreased expression/mutation of TGF␤ receptor II. 30 This lack of response to TGF␤ leads to increased secretion of the cytokine due to a loss of negative feedback regulation in the tumor cells. Pancreatic cancer cells have also been reported to secrete insulinlike growth factor (IGF), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), PDGF, and hepatocyte growth factor. 27 Our group and others demonstrated previously that cultured PSCs can be activated when exposed to at least 3 of the growth factors noted above, namely, TGF␤, PDGF, and bFGF. 17, 19 It is possible therefore that these growth factors are part of an array of factors that mediate pancreatic tumor cellinduced PSC activation in vivo.
PSCs activated by pancreatic cancer cells may promote and/or facilitate local and distant tumor invasion via 2 major pathways: (i) Secretion of proteolytic matrix-degrading enzymes by PSCs. Studies of pancreatic and other cancers indicate that matrix metalloproteinases (MMPs) play a crucial role in the degradation of extracellular matrix. Increased MMP expression (correlating with the degree of basement membrane disruption) has been demonstrated in ampullary cancers 31 and invasive ductal adenocarcinoma. 32 Overexpression of MMPs has also been demonstrated in gastric and colorectal cancer and has been correlated with tumor stage and grading. 33 Enhanced MMP expression has been reported in hepatocellular carcinoma associated with capsule invasion and intrahepatic metastases. 34 In all of these studies, the emphasis has been on production of MMPs by tumor cells. However, using zymographic techniques, we recently demonstrated that PSCs can secrete numerous MMPs. 35 The most abundant of these is MMP2, an enzyme known to degrade basement membrane collagen. In addition, we have shown that the secretion of MMP2 is significantly increased upon activation of PSCs by cytokines. Thus, it is not unreasonable to speculate that activation of PSCs by tumor cell secretions leads to increased MMP2 production by PSCs with consequent degradation giogenesis is an important component of the desmoplastic reaction in pancreatic cancer. 10 Angiogenesis is known to be stimulated by numerous factors including vascular endothelial growth factor (VEGF), bFGF, PDGF, TGF␤, and IGF1. It is of interest to note that the expression of IGF1 and bFGF has been shown to be upregulated in pancreatic cancer, not only in neoplastic areas but also in the surrounding stromal elements, 27 suggesting that stromal cells may have the capacity to synthesize these factors. Studies with cultured PSCs have established that these cells are also capable of producing TGF␤. 36 Therefore, tumor cell-induced activation of PSCs has the potential to lead to increased production of angiogenic factors. The resulting stimulation of new blood vessel formation in the stroma would encourage cancer progression by delivering nutrients and oxygen to tumor cells to promote local growth and allowing tumor cells to intravasate, thereby promoting distant metastasis.
Summary
Our study is the first to provide evidence that the stromal cells in pancreatic cancer are PSCs and that these cells are the major source of collagen within the desmoplastic reaction. The study also demonstrated the existence of an interaction between pancreatic cancer cells and PSCs, suggesting that pancreatic cancer cells in vivo may have the capacity to alter the behavior of surrounding stromal cells such that cancer progression is potentiated. Inhibition of tumor cell-induced PSC activation may represent a novel therapeutic strategy for pancreatic cancer.
